Vivotif
Total Payments
$46,405
Transactions
15
Doctors
3
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $292.56 | 2 | 2 |
| 2023 | $13,650 | 4 | 1 |
| 2022 | $32,463 | 9 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $46,113 | 13 | 99.4% |
| Food and Beverage | $292.56 | 2 | 0.6% |
Top Doctors Receiving Payments for Vivotif
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Pediatrics | San Francisco, CA | $46,113 | 13 |
| , FNP | Family | Farmington, NM | $146.28 | 1 |
| Anne Murphy | Family | Parker, CO | $146.28 | 1 |
Ad
Manufacturing Companies
- Emergent BioSolutions Inc. $46,113
- Bavarian Nordic A/S $292.56
Product Information
- Type Drug
- Total Payments $46,405
- Total Doctors 3
- Transactions 15
About Vivotif
Vivotif is a drug associated with $46,405 in payments to 3 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is Emergent BioSolutions Inc..
Payment data is available from 2022 to 2024. In 2024, $292.56 was paid across 2 transactions to 2 doctors.
The most common payment nature for Vivotif is "Consulting Fee" ($46,113, 99.4% of total).